UY23449A1 - Procedimiento para la preparacion de una combinacion antihipertensiva.- - Google Patents

Procedimiento para la preparacion de una combinacion antihipertensiva.-

Info

Publication number
UY23449A1
UY23449A1 UY23449A UY23449A UY23449A1 UY 23449 A1 UY23449 A1 UY 23449A1 UY 23449 A UY23449 A UY 23449A UY 23449 A UY23449 A UY 23449A UY 23449 A1 UY23449 A1 UY 23449A1
Authority
UY
Uruguay
Prior art keywords
atoms
phenyl
alkyl
radical
halogen
Prior art date
Application number
UY23449A
Other languages
English (en)
Inventor
Jean-Paul Clozel
Rita Müller
Wolfgang Osterrieder
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of UY23449A1 publication Critical patent/UY23449A1/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50Pyridazines; Hydrogenated pyridazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Plant Substances (AREA)
  • External Artificial Organs (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Se describe un procedimiento para la preparación de composiciones sinérgicas caracterizando por una mezclas de 2-[2-[[3-(2-bencimidazolil)propil]metilamino]etil]-6-fluoro-1.2.3.4-tetrahidro-1alfa-isopropil-2-alfa-naftil-metoxiacetato o [1S,2S]-2-[2-[[3-(2-bencimidazolil)propil]metilamino]etil]-6-fluoro-1,2,3,4-tetrahidro-1-isopropil-2-naftilmetoxiacetato dihidroclorido como un derivado del tetrahidronaftaleno y 9(S)-[1(S)-[1(S)-etoxicarbonil-3-fenilpropilamino]octahidro-10-oxo-6H-piridazo[1,2-a] [1,2] diacepina-1-(S)-ácido carboxílico como una piridazodiacepina en la forma de sus bases libres, sus hidratos o sus sales farmaceuticamente aceptables. El compuesto se usa como antihipertensivo.
UY23449A 1991-07-23 1992-07-22 Procedimiento para la preparacion de una combinacion antihipertensiva.- UY23449A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH219191 1991-07-23

Publications (1)

Publication Number Publication Date
UY23449A1 true UY23449A1 (es) 1993-01-21

Family

ID=4228024

Family Applications (1)

Application Number Title Priority Date Filing Date
UY23449A UY23449A1 (es) 1991-07-23 1992-07-22 Procedimiento para la preparacion de una combinacion antihipertensiva.-

Country Status (31)

Country Link
US (1) US5620975A (es)
EP (1) EP0524512B1 (es)
JP (1) JPH0680009B2 (es)
KR (1) KR100260479B1 (es)
CN (1) CN1040505C (es)
AT (1) ATE260661T1 (es)
AU (1) AU656207B2 (es)
BG (1) BG60949B1 (es)
BR (1) BR9202830A (es)
CA (1) CA2074039C (es)
CZ (1) CZ281691B6 (es)
DE (1) DE59209993D1 (es)
DK (1) DK0524512T3 (es)
ES (1) ES2215160T3 (es)
HR (1) HRP930953B1 (es)
HU (1) HU214029B (es)
IE (1) IE922378A1 (es)
IL (1) IL102541A (es)
IS (1) IS3887A (es)
MX (1) MX9204212A (es)
MY (1) MY118064A (es)
NO (1) NO301047B1 (es)
NZ (1) NZ243577A (es)
PT (1) PT524512E (es)
RO (1) RO110905B (es)
RU (1) RU2084225C1 (es)
SK (1) SK278918B6 (es)
TW (1) TW216770B (es)
UY (1) UY23449A1 (es)
YU (2) YU72392A (es)
ZA (1) ZA925322B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE198551T1 (de) * 1993-07-15 2001-01-15 Hoffmann La Roche Pharmazeutische kombination, die einen hemmer des renin-angiotensin-systems und einen endothelin- antagonisten enthält
IL131816A (en) 1997-04-04 2003-06-24 Exxon Res & Engineering Compan Composite structures having high containment strength
CA2462913A1 (en) 2001-10-10 2003-04-17 Aryx Therapeutics Mibefradil-based compounds as calcium channel blockers useful in the treatment of hypertension and angina
US7687086B1 (en) 2003-02-28 2010-03-30 University Of Portland Method for obtaining taxanes
EP2537534B1 (en) 2011-06-22 2014-12-17 Hexal AG Esters of (1S,9S)-9-[[(1S)-1-carboxy-3-phenylpropyl]amino]octahydro-10-oxo-6H-pyridazino[1,2-a][1,2]diazepine-1-carboxylic acid and their therapeutic use.

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2128984B (en) * 1982-05-12 1985-05-22 Hoffmann La Roche Diaza-bicyclic compounds
DE3542794A1 (de) * 1985-12-04 1987-06-11 Bayer Ag Antihypertensives kombinationspraeparat
CA1319144C (en) * 1986-11-14 1993-06-15 Quirico Branca Tetrahydronaphthalene derivatives
FR2607004B1 (fr) * 1986-11-20 1990-06-01 Synthelabo Compositions pharmaceutiques contenant du diltiazem et un inhibiteur de l'enzyme de conversion de l'angiotensine
US5110813A (en) * 1987-09-15 1992-05-05 Alcoholism And Drug Addiction Research Foundation Reduction of voluntary alcohol consumption by treatment with angiotensin converting enzyme inhibitors
US4871731A (en) * 1987-10-07 1989-10-03 Marion Laboratories, Inc. Captopril and diltiazem composition and the like
KR940005408B1 (ko) * 1990-12-03 1994-06-18 만도기계 주식회사 파워 윈도우 모우터 회전자의 선단부 흔들림 측정장치

Also Published As

Publication number Publication date
CA2074039A1 (en) 1993-01-24
CN1040505C (zh) 1998-11-04
HRP930953B1 (en) 2003-06-30
MX9204212A (es) 1993-08-01
EP0524512A2 (de) 1993-01-27
IL102541A (en) 1995-12-08
HU9202367D0 (en) 1992-10-28
IS3887A (is) 1993-01-24
IL102541A0 (en) 1993-01-14
US5620975A (en) 1997-04-15
MY118064A (en) 2004-08-30
CA2074039C (en) 2004-11-02
AU656207B2 (en) 1995-01-27
KR100260479B1 (ko) 2000-07-01
NO922903L (no) 1993-01-25
JPH0680009B2 (ja) 1994-10-12
HUT62792A (en) 1993-06-28
BR9202830A (pt) 1993-03-23
YU49198B (sh) 2004-09-03
RO110905B (ro) 1996-05-30
AU2041692A (en) 1993-01-28
CN1068737A (zh) 1993-02-10
RU2084225C1 (ru) 1997-07-20
ES2215160T3 (es) 2004-10-01
SK278918B6 (sk) 1998-04-08
KR930001910A (ko) 1993-02-22
BG60949B1 (bg) 1996-07-31
TW216770B (es) 1993-12-01
NO922903D0 (no) 1992-07-22
YU72392A (sh) 1997-05-28
EP0524512A3 (en) 1993-09-01
NZ243577A (en) 1994-09-27
ZA925322B (en) 1993-03-31
NO301047B1 (no) 1997-09-08
ATE260661T1 (de) 2004-03-15
DE59209993D1 (de) 2004-04-08
DK0524512T3 (da) 2004-07-05
HU214029B (en) 1997-12-29
CZ227092A3 (en) 1993-02-17
HRP930953A2 (en) 1995-10-31
IE922378A1 (en) 1993-01-27
EP0524512B1 (de) 2004-03-03
JPH05194217A (ja) 1993-08-03
CZ281691B6 (cs) 1996-12-11
PT524512E (pt) 2004-07-30
SK227092A3 (en) 1996-02-07

Similar Documents

Publication Publication Date Title
ES2081120T3 (es) Procedimiento para la preparacion de derivados de la bacatina iii y la desacetil-10 bacatina iii.
KR930703319A (ko) 키산틴 유도체
FI881950A0 (fi) Hyönteisten ja punkkien karkoitteet
DE3676763D1 (de) Indolcarboxamidderivate, ihre salze, verfahren und zwischenprodukte, anwendung als heilmittel und zusammensetzungen die sie enthalten.
ATE95816T1 (de) 2-((4-piperidinyl)methyl>-1,2,3,4tetrahydroisochinolin-derivate, ihre herstellung und ihre therapeutische verwendung.
UY23449A1 (es) Procedimiento para la preparacion de una combinacion antihipertensiva.-
NZ221314A (en) 1,4-dihydropyridine derivatives and pharmaceutical composition
MX9633A (es) Procedimiento para la preparacion de nuevos productos esteroides que llevan en la posicion 23 un radical sulfinilo y producto obtenido.
SE8800863D0 (sv) 3-(2-haloethyl)-1,4-oxathiins and 2-(2-haloethyl)-1,4-dithiins and treatment of leukemia and tumors therewith
FI890187A0 (fi) Foerfarande foer framstaellning av hydroxialkylerande foereningar, saolunda erhaollna nya foereningar och deras anvaendning.
NZ221004A (en) 2,6-piperazinediones and pharamceutical compositions
AU3626189A (en) New derivatives of phenothiazine, their preparation and the compositions which contain them
ZA80742B (en) Thiazole derivatives and their use in therapy
ATE64383T1 (de) 8-phenylthiotetrahydrochinolin-derivate und ihre salze, ihre herstellung, verwendung als arzneimittel und zusammensetzungen davon.

Legal Events

Date Code Title Description
VENC Patent expired

Effective date: 20130731